Koninklijke DSM NV (MEX:DSM)

MXN 2194.2 0 (0%) Market Cap: 4.36 Bil Enterprise Value: 8.03 Bil PE Ratio: 2.47 PB Ratio: 0.46 GF Score: 57/100

Q1 2023 Koninklijke DSM NV Trading Statement Call Transcript
May 02, 2023
Full Year 2022 Koninklijke DSM NV Earnings Call Transcript
Feb 16, 2023

MXN2769.06

Earnings
Koninklijke DSM NV and Firmenich to Announce Launch of the Exchange Offer Call Transcript
Nov 22, 2022
Q3 2022 Koninklijke DSM NV Trading Statement Call Transcript
Nov 01, 2022
Half Year 2022 Koninklijke DSM NV Earnings Call Transcript
Aug 02, 2022

MXN2769.06

Earnings
Koninklijke DSM NV and Firmenich International SA Capital Markets Day Transcript
Jun 13, 2022
Koninklijke DSM NV to Discuss Merger with Firmenich International SA Call Transcript
May 31, 2022
Koninklijke DSM NV Annual Shareholders Meeting Transcript
May 10, 2022
Q1 2022 Avient Corp Earnings & Acquisition Of DSM Protective Materials (Dyneema) Call Transcript
Apr 20, 2022
Full Year 2021 Koninklijke DSM NV Earnings Call Transcript
Feb 15, 2022

MXN4147.15

Earnings
Koninklijke DSM NV Accelerates its Purpose-Led, Performance-Driven Strategic Journey Call Transcript
Sep 14, 2021
Half Year 2021 Koninklijke DSM NV Earnings Call Transcript
Aug 03, 2021

MXN4022.23

Earnings
Koninklijke DSM NV Annual Shareholders Meeting Transcript
May 06, 2021
Q4 2020 Koninklijke DSM NV Earnings Call Transcript
Feb 16, 2021

MXN2453.41

Earnings
Q4 2020 Koninklijke DSM NV Earnings Press Conference Transcript
Feb 16, 2021
Koninklijke DSM NV Virtual Investor Event Transcript
Nov 04, 2020
Q3 2020 Koninklijke DSM NV Earnings Call Transcript
Nov 03, 2020

MXN2453.41

Earnings
Q2 2020 Koninklijke DSM NV Earnings Call Transcript
Aug 04, 2020

MXN2453.41

Earnings
Koninklijke DSM NV Annual Shareholders Meeting Transcript
May 08, 2020
Q1 2020 Koninklijke DSM NV Earnings Call Transcript
May 07, 2020

Earnings
Q4 2019 Koninklijke DSM NV Earnings Call Transcript
Feb 13, 2020

Earnings
Q3 2019 Koninklijke DSM NV Earnings Call Transcript
Nov 05, 2019

MXN2453.41

Earnings
Q2 2019 Koninklijke DSM NV Earnings Call Transcript
Aug 01, 2019

MXN2346.72

Earnings
Koninklijke DSM NV Annual Shareholders Meeting Transcript
May 08, 2019
Q1 2019 Koninklijke DSM NV Earnings Call Transcript
May 07, 2019

MXN1760.05

Earnings
Q4 2018 Koninklijke DSM NV Earnings Call Transcript
Feb 14, 2019

MXN1760.05

Earnings

Koninklijke DSM NV Annual Shareholders Meeting Transcript

May 08, 2019 / 12:00PM GMT

Release Date Price: MXN1760.05

Transcript

Robert J. Routs

Koninklijke DSM N.V. - Chairman of Supervisory Board

[Interpreted] Ladies and gentlemen, can we open the meeting? It's wonderful to see so many people in the room, and I hope we'll have a very pleasant and interesting meeting. I hereby open the meeting and welcome all of you, both the shareholders as all those who are interested and all guests. Given the fact that we have a live feed on the web page of DSM, I also want to welcome all those who attend the meetings through this means. And for those present for the first time, my name is Rob Routs, and I am Chairman of the Supervisory Board of Royal DSM.

On the podium behind me, you find members of the Supervisory Board: Pauline van der Meer Mohr, Eileen Kennedy, Victoria Haynes, Frits van Paasschen, John Ramsay and Pradeep Pant. Also present among us, Erica Mann, her appointment is on the agenda today. In the first row, you find the members of the Managing Board. Feike Sijbesma, Geraldine Matchett, and Dimitri de Vreeze. Next to me, Louisa van den Broek, Corporate Secretary. She'll draw up the minutes of today's meeting. Present in

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.